Related Experiment Video
Updated: Apr 6, 2026

07:05
Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
Published on: January 20, 2019
57.3K
Clinicopathological features of breast angiosarcoma
Kyohei Masai1, Takayuki Kinoshita2, Kenjiro Jimbo2
1Breast Surgery Division, National Cancer Center Hospital, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo, 104-0045, Japan. kmasai@ncc.go.jp.
Breast Cancer (Tokyo, Japan)
|August 6, 2015
Summary
Breast angiosarcoma, a rare cancer, shows high recurrence rates. Early detection and total mastectomy with adequate margins are crucial for better survival outcomes in these aggressive tumors.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Breast angiosarcomas are rare neoplasms with limited therapeutic strategies.
- Investigating clinicopathologic features and treatment outcomes is essential due to rarity.
Purpose of the Study:
- To investigate the clinicopathologic features of breast angiosarcoma.
- To examine treatment strategies and compare outcomes with existing literature.
Main Methods:
- Retrospective chart and slide review of patients diagnosed with primary or secondary breast angiosarcoma.
- Data collected from 1997 to 2012 at the National Cancer Center Hospital, Tokyo, Japan.
Main Results:
- Nine patients diagnosed: six primary, three secondary breast angiosarcomas.
- Primary angiosarcoma: median age 39, median tumor size 6.78 cm. 5-year survival rate was 50%.
- Secondary angiosarcoma: all cases recurred; one achieved long-term survival with local control therapy.
Conclusions:
- Breast angiosarcoma exhibits high recurrence rates.
- Tumor size and surgical margins are critical for long-term survival.
- Total mastectomy with adequate margins and early detection are recommended; local recurrence may be curable with surgery.
Related Concept Videos
Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Metastasis
6.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K

